We have demonstrated that sdAb-QD conjugates are effective tools to detect disseminated human tumour cells and micrometastases by binding HER2 and CEA, two antigens overexpressed in metastatic breast and pancreatic tumours, respectively. Here, ERBB2 is linked to pancreatic neoplasm.